Dr. Ramaswamy Govindan Describes the Cancer Genome Atlas Project

Ramaswamy Govindan, Washington University School of Medicine, USA:Подробнее

Dr. Govindan on Genomic Characterization of Large-Cell Neuroendocrine Lung TumorsПодробнее

The Cancer Genome Atlas Project at Nationwide Children'sПодробнее

How will The Cancer Genome Atlas Project Improve Patient Care?Подробнее

Dr. Ramaswamy Govindan talks about genetics in cancerПодробнее

Dr. Ramaswamy Govindan talks about modern cancer treatmentПодробнее

Grand Rounds 2021.01.27Подробнее

Large-Scale Cancer Genomics Data Analysis - David HausslerПодробнее

Ramaswamy Govindan, M.D., KRAS Targeted Therapies, KRAS Kickers Connect, September 25, 2021Подробнее

ESMO 2014: Lung CancerПодробнее

Dr. Govindan on the Future of EGFR-Mutant NSCLCПодробнее

Progress and Promise in Lung Cancer ResearchПодробнее

ECDP 2019 | The Cancer Genome Atlas: A usable resource?Подробнее

What’s on the Horizon for Immunotherapy in NSCLC?Подробнее

TCGA: Comprehensive Analysis of Lung Adenocarcinoma - Matthew MeyersonПодробнее

Govindan Discusses the Phase I Results of AMG 510 Evaluated in NSCLCПодробнее

Researcher comment: AMG 510 for KRAS mutation-positive NSCLC | Ramaswamy GovindanПодробнее